Search Results 431-440 of 16525 for immunosuppressant drugs

  1. Imiquimod (topical route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Pain medicines after surgery - Mayo Clinic

    You may need to change your medicines before and after surgery. Alcohol and drug use. Accurately describe your current use of alcohol, tobacco or illicit drugs.

  3. Darunavir (oral route) - Mayo Clinic

    This medicine is given to patients who have already had previous treatment for HIV or who have never taken HIV medicines in the past. Darunavir will not cure or ...

  4. Sulbactam and durlobactam (intravenous route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Liver Transplant - Eligibility - Mayo Clinic

    A care team member will talk with you about the importance of taking your immunosuppressant (anti-rejection) medications to keep your body from rejecting your ...

  6. Spiramycin (oral route, injection route, rectal route) - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  7. Allan B. Dietz, Ph.D. - Mayo Clinic Faculty Profiles

    Dietz focuses on the use of cells as drugs. Dr ... Dietz and his colleagues have described the immunosuppressive effects of monocytes and seek to understand their ...

  8. Pirfenidone (oral route) - Mayo Clinic

    Pirfenidone is used to treat idiopathic pulmonary fibrosis. This medicine is available only with your doctor's prescription. This product is available in the ...

  9. Emapalumab-lzsg (intravenous route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  10. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

    not requiring immunosuppressive treatment are eligible. - Absolute neutrophil count (ANC) ≥ 1,000/mm^3. - Platelet count ≥ 100,000/mm^3. - Hemoglobin ≥ 8 ...